Interventional device developer Boston Scientific of Natick, MA, said it has modified its credit line with its lenders for more financial flexibility.
The company has amended its $2 billion revolving line of credit and $5 billion term loan agreement. Also with the amended agreement, Boston Scientific prepaid $1 billion of its term loan using $750 million from cash on hand and $250 million from another creditor.
By AuntMinnie.com staff writers
August 23, 2007
Related Reading
Boston Scientific mulls sale of cardiac, vascular surgery businesses, August 17, 2007
Boston Scientific to keep Endosurgery unit, August 3, 2007
Boston Scientific begins Taxus Element stent trial, July 20, 2007
Boston Scientific brings Taxus Express² to Japan, May 8, 2007
Boston Scientific gets Japanese nod for Taxus, April 3, 2007
Copyright © 2007 AuntMinnie.com